Extended radical cholecystectomy with curative potential for well selected locally advanced carcinoma gall bladder: a case report and review of literature

Authors

  • Pradeep Thammaiah Department of Surgical Oncology, Santhiram Medical College, Nandyal, Andra Pradesh, India

DOI:

https://doi.org/10.18203/2349-2902.isj20222606

Keywords:

Carcinoma gall bladder, Locally advanced, Neoadjuvant chemotherapy, Adjuvant therapy, R0 resection, Survival

Abstract

Gallbladder cancer is an aggressive malignancy that is associated with a poor prognosis. While surgical resection provides the only curative option, the majority of patients are not considered resectable due to locally advanced disease and presence of metastatic disease at the time of presentation. Here we presented a case of 46-year-old female with symptoms and initial workup suggestive of obstructive jaundice with cholestasis. PET-CT demonstrated heterogeneously enhancing mass lesion arising from neck of gallbladder and involving adjacent liver parenchyma with FDG avid para-aortic nodes. Liver biopsy confirmed adenocarcinoma, ERCP revealed tight hilar structure and CBD stent was placed. Patient was diagnosed with cT4, N2 carcinoma gall bladder and received two cycles of neoadjuvant chemotherapy (NACT) with gemcitabine and cisplatin. In view of localized and stable disease following NACT, patient underwent radical cholecystectomy with wide liver resection involving segment 4b and 5 with hepatoduodenal, portocaval and aortocaval lymph node dissection. Patient had post-operative complications, managed conservatively. On follow up patient had improved appetite, gained weight adequately, received adjuvant chemotherapy and is disease free till date. Carefully selected patients may benefit from an aggressive surgical approach following upfront systemic chemotherapy.

Author Biography

Pradeep Thammaiah, Department of Surgical Oncology, Santhiram Medical College, Nandyal, Andra Pradesh, India

consultant/assistant professor - surgical oncology

References

Mahdavifar N, Mohammadian M, Salehiniya H. Gall bladder cancer in the world: Epidemiology, incidence, mortality and risk factors. World Cancer Res J. 2018;5(3):e1124.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53.

Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211-7.

Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167-76.

Engineer R, Goel M, Chopra S, Patil P, Purandare N, Rangarajan V, et al. Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm. Ann Surg Oncol. 2016;23(9):3009-15.

Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, et al. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. J Am Coll Surg. 2017;224(5):906-16.

Chaudhari VA, Ostwal V, Patkar S, Sahu A, Toshniwal A, Ramaswamy A, et al. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications. HPB (Oxford). 2018;20(9):841-7.

Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232(4):557-69.

Piehler JM, Crichlow RW. Primary carcinoma of the gallbladder. Surg Gynecol Obstet. 1978;147(6):929-42.

Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg. 1994;219(3):275-80.

Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. Aust N Z J Surg. 1995;65(10):724-7.

Dixon E, Vollmer CM, Sahajpal A, Cattral M, Grant D, Doig C, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241(3):385-94.

Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89(2):179-84.

Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol. 2014;40(8):1008-15.

Nishio H, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253(5):953-60.

Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273-81.

Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, Kulkarni S, Goel M, Shrikhande SV. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015;11(10):1501-9.

Downloads

Published

2022-09-28

Issue

Section

Case Reports